These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29432026)

  • 1. Developmental Trajectories of Executive and Verbal Processes in Children with Phenylketonuria.
    Hawks ZW; Strube MJ; Johnson NX; Grange DK; White DA
    Dev Neuropsychol; 2018; 43(3):207-218. PubMed ID: 29432026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Executive strategic processing during verbal fluency performance in children with phenylketonuria.
    Banerjee P; Grange DK; Steiner RD; White DA
    Child Neuropsychol; 2011; 17(2):105-17. PubMed ID: 21140312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical executive function impairment in children with asymptomatic, treated phenylketonuria: A comparison with children with immunodeficiency virus.
    Bisiacchi P; Mento G; Tarantino V; Burlina A
    Cogn Neuropsychol; 2018; 35(3-4):200-208. PubMed ID: 29117799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive response monitoring and inhibitory control in children with phenylketonuria: effects of expectancy.
    Araujo GC; Christ SE; Grange DK; Steiner RD; Coleman C; Timmerman E; White DA
    Dev Neuropsychol; 2013; 38(3):139-52. PubMed ID: 23573793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing speed and executive abilities in children with phenylketonuria.
    Janos AL; Grange DK; Steiner RD; White DA
    Neuropsychology; 2012 Nov; 26(6):735-43. PubMed ID: 22866986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-Up of Cognition and Mental Health in Adult Phenylketonuria: A PKU-COBESO Study.
    Jahja R; van Spronsen FJ; de Sonneville LMJ; van der Meere JJ; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; Huijbregts SCJ
    Behav Genet; 2017 Sep; 47(5):486-497. PubMed ID: 28776207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
    Boot E; Hollak CEM; Huijbregts SCJ; Jahja R; van Vliet D; Nederveen AJ; Nieman DH; Bosch AM; Bour LJ; Bakermans AJ; Abeling NGGM; Bassett AS; van Amelsvoort TAMJ; van Spronsen FJ; Booij J
    Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive outcomes in early-treated adults with phenylketonuria (PKU): A comprehensive picture across domains.
    Palermo L; Geberhiwot T; MacDonald A; Limback E; Hall SK; Romani C
    Neuropsychology; 2017 Mar; 31(3):255-267. PubMed ID: 28080075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White and gray matter brain development in children and young adults with phenylketonuria.
    Hawks Z; Hood AM; Lerman-Sinkoff DB; Shimony JS; Rutlin J; Lagoni D; Grange DK; White DA
    Neuroimage Clin; 2019; 23():101916. PubMed ID: 31491833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological Profile of Children with Early and Continuously Treated Phenylketonuria: Systematic Review and Future Approaches.
    Canton M; Gall DL; Feillet F; Bonnemains C; Roy A
    J Int Neuropsychol Soc; 2019 Jul; 25(6):624-643. PubMed ID: 31030702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of blood phenylalanine level variations on the development of executive functions and social cognition in children with phenylketonuria.
    de Almeida Duarte CM; Piazzon FB; Rocco IS; de Mello CB
    J Pediatr (Rio J); 2023; 99(5):507-513. PubMed ID: 37178714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing is everything: executive functions in children exposed to elevated levels of phenylalanine.
    Antshel KM; Waisbren SE
    Neuropsychology; 2003 Jul; 17(3):458-68. PubMed ID: 12959512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Outcomes and Relationships with Phenylalanine in Phenylketonuria: A Comparison between Italian and English Adult Samples.
    Romani C; Manti F; Nardecchia F; Valentini F; Fallarino N; Carducci C; De Leo S; MacDonald A; Palermo L; Leuzzi V
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33022955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response monitoring in children with phenylketonuria.
    Araujo GC; Christ SE; Steiner RD; Grange DK; Nardos B; McKinstry RC; White DA
    Neuropsychology; 2009 Jan; 23(1):130-4. PubMed ID: 19210041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria.
    White DA; Nortz MJ; Mandernach T; Huntington K; Steiner RD
    J Int Neuropsychol Soc; 2002 Jan; 8(1):1-11. PubMed ID: 11843066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, placebo-controlled, double-blind study of sapropterin to treat ADHD symptoms and executive function impairment in children and adults with sapropterin-responsive phenylketonuria.
    Burton B; Grant M; Feigenbaum A; Singh R; Hendren R; Siriwardena K; Phillips J; Sanchez-Valle A; Waisbren S; Gillis J; Prasad S; Merilainen M; Lang W; Zhang C; Yu S; Stahl S
    Mol Genet Metab; 2015 Mar; 114(3):415-24. PubMed ID: 25533024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.
    Romani C; Palermo L; MacDonald A; Limback E; Hall SK; Geberhiwot T
    Neuropsychology; 2017 Mar; 31(3):242-254. PubMed ID: 28240926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological profile in parents of adult phenylketonuria patients.
    Santangelo G; Piscopo F; Santangelo F; Trojano L
    Neurol Sci; 2018 Jan; 39(1):161-164. PubMed ID: 29124442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executive function in phenylketonuria (PKU): Insights from the Behavior Rating Inventory of Executive Function (BRIEF) and a large sample of individuals with PKU.
    Christ SE; Clocksin HE; Burton BK; Grant ML; Waisbren S; Paulin MC; Bilder DA; White DA; Saville C
    Neuropsychology; 2020 May; 34(4):456-466. PubMed ID: 32202818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.